PPT-Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial
Author : OneAndOnly | Published Date : 2022-08-04
VA Cooperative Studies Program Trial 578 ContrastAssociated Acute Kidney Injury CAAKI Common post angiography amp associated with death dialysis progressive CKD
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Prevention of Serious Adverse Events Fol..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial: Transcript
VA Cooperative Studies Program Trial 578 ContrastAssociated Acute Kidney Injury CAAKI Common post angiography amp associated with death dialysis progressive CKD Potentially preventable . Widgeon Point Preserve Widgeon Point Preserve i i i On Lemon Island On Lemon Island On Lemon Island i i i Bird Watching Small Weddings Family Gatherings Oyster Roasts Rehearsal Dinners Office Retre Kamran Ahrar, M.D.. Elizabeth Ninan, PA-C. Jasmine NovoGradac, MBA,BSN,. RN. Terrell Evans, RT. (R)(CT)(MR). Division of Diagnostic Imaging. Section. of Interventional Radiology. 2. Background. Limited Capacity. Giuseppe . Biondi-Zoccai. , MD. Sapienza University . of. . Rome. , Italy. giuseppe.biondizoccai@uniroma1.it. Learning. . goals. Scope . of. the . problem. Rationale. . for. . emergency. . coronary. S. Percy Ivy, MD. Associate Chief, Senior Investigator. Investigational Drug Branch, National Cancer Institute. ivyp@ctep.nci.nih.gov. . National Cancer Institute. . National Cancer Institute. Florida Forest Service. Babcock Ranch Preserve . “A Brief History”. Occupying land in both Charlotte and Lee Counties, the Babcock “Crescent B” Ranch spanned 91,361 acres prior to acquisition. . S. Percy Ivy, MD. Associate Chief, Senior Investigator. Investigational Drug Branch, National Cancer Institute. ivyp@ctep.nci.nih.gov. . National Cancer Institute. . National Cancer Institute. Clinical and Institutional Disclosure of Adverse Events to Patients Call 1 of 2 Delivered May 21, 2012 updated to reflect directive’s reissue (October 31, 2018) Sponsoring Offices: National Center for Ethics in Health Care Table I What is angiogram?. Angiography is a specialized test which is used to examine the state and functioning of the arteries in our heart. The arteries are the important blood vessels that carry oxygenated blood from the heart to the various parts of the body. When a person suffers from a chest pain, which is also known as angina, it becomes necessary to get an angiography done. Angiographies are done in order to study the biology of blood vessels like the arteries and the veins. In short, it is the inspection of the condition inside the 'tubular structures' in the body.. The RIPCORD 2 Trial. Stables R, Mullen L, . Elguindy. M, Nicholas Z, . Aboul-Enien. Y, Kemp I, O’Kane P, Hobson A, Johnson T, Khan S, Wheatcroft S, Garg S, Zaman A, Mamas MA, Nolan J, Jadhav S, Berry C, Watkins S, . Bo Xu, . Shengxian. Tu, Lei Song, . Zening. . Jin. , Bo Yu, . Guosheng. Fu, . Yujie. Zhou, . Jian’an. Wang, . Yundai. Chen, Jun Pu, . Lianglong. Chen, . Xinkai. Qu, . Junqing. Yang, . Xuebo. Dermatitis. Diarrhea/colitis . Endocrinopathies. including hyper or hypothyroidism, adrenal insufficiency or diabetes (including diabetic ketoacidosis). Other toxicities including: cardiac, ocular, hematological, myopathies and neurological (including paresis, Guillain-Barré and encephalitis). EVENTS AND COMPLETING THE REPORT FORM. Trial protocol code: ISRCTN30952488. Version 2. , . 21 Nov 2017. USE THIS . PRESENTATION . WITH. :. The Trial Protocol (. Section 2.9). . and . G. uidance. . for investigators: . Events. Robert Silbergleit, MD. Adverse Events – . key points. Do not report events EXISTING PRIOR to randomization . (unless there is a change in severity). Report the DIAGNOSIS, not the symptoms:.
Download Document
Here is the link to download the presentation.
"Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents